Real-world effectiveness of lenvatinib monotherapy among previously treated unresectable hepatocellular carcinoma patients in United States clinical practices.

被引：0
|
作者：
Singal, Amit G.
Nagar, Saurabh P.
Hitchens, Abigail
Iyer, Shrividya
机构：
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] RTI Int, Res Triangle Pk, NC USA
[4] Eisai Inc, Woodcliff Lake, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16129
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients treated in United States clinical practices.
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abigail
    Iyer, Shrividya
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] Real-world effectiveness of lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    CANCER REPORTS, 2023, 6 (01)
  • [3] Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    FUTURE ONCOLOGY, 2021, 17 (21) : 2759 - 2768
  • [4] Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
    Li, Daneng
    Gruber, Stephen B.
    Iyer, Shrividya
    Gupta, Sanjay
    Tejani, Mohamedtaki
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (10) : 1796 - 1806
  • [5] Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice
    Furuse, Junji
    Izumi, Namiki
    Motomura, Kenta
    Inaba, Yoshitaka
    Katamura, Yoshio
    Kondo, Yasuteru
    Yabushita, Kazuhisa
    Matsuoka, Toshiyuki
    Motoyoshi, Katsuaki
    Kudo, Masatoshi
    CANCERS, 2025, 17 (03)
  • [6] Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
    Finn, Richard S.
    Iyer, Renuka
    Kalman, Richard S.
    Parikh, Neehar D.
    Cabrera, Roniel
    Babajanyan, Svetlana
    Kaseb, Ahmed O.
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2025, 12 : 231 - 246
  • [7] Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03)
  • [8] Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Kariyama, Kazuya
    Takaguchi, Koichi
    Atsukawa, Masanori
    Itobayashi, Ei
    Tsuji, Kunihiko
    Tajiri, Kazuto
    Hirooka, Masashi
    Shimada, Noritomo
    Shibata, Hiroshi
    Ishikawa, Toru
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Itokawa, Norio
    Imai, Michitaka
    Joko, Kouji
    Hiasa, Yoichi
    Michitaka, Kojiro
    CANCER MEDICINE, 2019, 8 (01): : 137 - 146
  • [9] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Chen, Kang
    Wei, Wei
    Liu, Lei
    Deng, Zhu-Jian
    Li, Le
    Liang, Xiu-Mei
    Guo, Ping-Ping
    Qi, Lu-Nan
    Zhang, Zhi-Ming
    Gong, Wen-Feng
    Huang, Shan
    Yuan, Wei-Ping
    Ma, Liang
    Xiang, Bang-De
    Li, Le-Qun
    Zhong, Jian-Hong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1063 - 1074
  • [10] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Kang Chen
    Wei Wei
    Lei Liu
    Zhu-Jian Deng
    Le Li
    Xiu-Mei Liang
    Ping-Ping Guo
    Lu-Nan Qi
    Zhi-Ming Zhang
    Wen-Feng Gong
    Shan Huang
    Wei-Ping Yuan
    Liang Ma
    Bang-De Xiang
    Le-Qun Li
    Jian-Hong Zhong
    Cancer Immunology, Immunotherapy, 2022, 71 : 1063 - 1074
12345